{
  "id": "bff5c5c47a9dc815",
  "title": "StockWatch : Cosmo Surges 40 % on Baldness Candidate Phase III Data",
  "description": "20251208T073000Z",
  "content": "",
  "source": "genengnews.com",
  "source_url": "https://www.genengnews.com/topics/translational-medicine/stockwatch-cosmo-surges-40-on-baldness-candidates-phase-iii-data/",
  "published_at": "20251208T073000Z",
  "fetched_at": "2025-12-09T00:22:19.510482+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.genengnews.com/topics/translational-medicine/stockwatch-cosmo-surges-40-on-baldness-candidates-phase-iii-data/",
    "url_mobile": "",
    "title": "StockWatch : Cosmo Surges 40 % on Baldness Candidate Phase III Data",
    "seendate": "20251208T073000Z",
    "socialimage": "https://www.genengnews.com/wp-content/uploads/2025/12/Cosmo-Pharma-entire-PDF-of-Picture1-CROPPED-2-patients.jpg",
    "domain": "genengnews.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}